- What is Evommune, Inc.'s Market Cap?
- Evommune, Inc.'s Market Cap is $284.5M, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s Enterprise Value?
- Evommune, Inc.'s Enterprise Value is $84.7M, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s Price / Sales?
- Evommune, Inc.'s Price / Sales is 28.5×, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s EV / Revenue?
- Evommune, Inc.'s EV / Revenue is 8.5×, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s EV / EBITDA?
- Evommune, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s Revenue (TTM)?
- Evommune, Inc.'s Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s Net Income (TTM)?
- Evommune, Inc.'s Net Income (TTM) is -$94.7M, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s EBITDA?
- Evommune, Inc.'s EBITDA is -$101.3M, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s Diluted EPS (TTM)?
- Evommune, Inc.'s Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.
- What is Evommune, Inc.'s EBITDA Margin?
- Evommune, Inc.'s EBITDA Margin is -1012.9%, based on as-reported figures from SEC (XBRL) filings.